Global Cancer (Tumor) Profiling Market Research Report 2019 (Includes Business Impact of COVID-19)
- TBI273182
- March 20, 2019
- Global
- 90 pages
- QY Market Research
The cancer/tumor profiling market in terms of technology has been segmented into next generation sequencing (NGS), quantitative polymerase chain reaction (QPCR), immunohistochemistry (IHC), in-situ hybridization (ISH), and microarray, based on technology.
Europe held the second largest share of 27.7% in the global cancer/tumor profiling market in 2017.
The global Cancer (Tumor) Profiling market is valued at 5260 million US$ in 2018 is expected to reach 12100 million US$ by the end of 2025, growing at a CAGR of 11.0% during 2019-2025.
This report focuses on Cancer (Tumor) Profiling volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer (Tumor) Profiling market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Illumina
Qiagen
Neogenomics Laboratories
HTG Molecular Diagnostics
Genomic Health
Caris Life Sciences
Helomics Corporation
Nanostring Technologies
Oxford Gene Technology
Ribomed Biotechnologies
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Immunoassay
Hybridization
NGS
Mass Spectrometry
Segment by Application
Clinical
Research
Table of Contents
Executive Summary
1 Cancer (Tumor) Profiling Market Overview
1.1 Product Overview and Scope of Cancer (Tumor) Profiling
1.2 Cancer (Tumor) Profiling Segment by Type
1.2.1 Global Cancer (Tumor) Profiling Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Immunoassay
1.2.3 Hybridization
1.2.4 NGS
1.2.5 Mass Spectrometry
1.3 Cancer (Tumor) Profiling Segment by Application
1.3.1 Cancer (Tumor) Profiling Consumption Comparison by Application (2014-2025)
1.3.2 Clinical
1.3.3 Research
1.4 Global Cancer (Tumor) Profiling Market by Region
1.4.1 Global Cancer (Tumor) Profiling Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Cancer (Tumor) Profiling Market Size
1.5.1 Global Cancer (Tumor) Profiling Revenue (2014-2025)
1.5.2 Global Cancer (Tumor) Profiling Production (2014-2025)
2 Global Cancer (Tumor) Profiling Market Competition by Manufacturers
2.1 Global Cancer (Tumor) Profiling Production Market Share by Manufacturers (2014-2019)
2.2 Global Cancer (Tumor) Profiling Revenue Share by Manufacturers (2014-2019)
2.3 Global Cancer (Tumor) Profiling Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Cancer (Tumor) Profiling Production Sites, Area Served, Product Types
2.5 Cancer (Tumor) Profiling Market Competitive Situation and Trends
2.5.1 Cancer (Tumor) Profiling Market Concentration Rate
2.5.2 Cancer (Tumor) Profiling Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Cancer (Tumor) Profiling Production Market Share by Regions
3.1 Global Cancer (Tumor) Profiling Production Market Share by Regions
3.2 Global Cancer (Tumor) Profiling Revenue Market Share by Regions (2014-2019)
3.3 Global Cancer (Tumor) Profiling Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Cancer (Tumor) Profiling Production
3.4.1 North America Cancer (Tumor) Profiling Production Growth Rate (2014-2019)
...
| read more...
Related Reports
